Structural mechanism for the specific assembly and activation of the extracellular signal regulated kinase 5 (ERK5) module

Journal of Biological Chemistry

Volumn 288, Issue 12, 2013, Pages 8596-8609

  Glatz, Gábor ^a   Gógl, Gergo ^a   Alexa, Anita ^a   Reményi, Attila ^a  

^a EÖTVÖS LORÁND UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL CHARACTERIZATION; CATALYTIC PROPERTIES; EXTRACELLULAR SIGNAL-REGULATED KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PHYSIOLOGICAL FUNCTIONS; PROTEIN INTERACTION; PROTEIN-PROTEIN INTERACTIONS; STRUCTURAL MECHANISMS;

CHEMICAL ACTIVATION; COMPLEX NETWORKS; PROTEINS; SUBSTRATES;

ENZYME ACTIVITY;

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE;

ARTICLE; CATALYSIS; CRYSTAL STRUCTURE; DOWNSTREAM PROCESSING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE;

AMINO ACID SEQUENCE; APOENZYMES; CATALYTIC DOMAIN; CRYSTALLOGRAPHY, X-RAY; ENZYME ACTIVATION; HEK293 CELLS; HUMANS; MAP KINASE KINASE 5; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 7; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MULTIPROTEIN COMPLEXES; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, SECONDARY; SURFACE PROPERTIES;

EID: 84875409408     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.452235     Document Type: Article

References (58)

1. Nishimoto, S., and Nishida, E. (2006) MAPK signalling: ERK5 versus ERK1/2. EMBO Rep. 7, 782-786 (Pubitemid 44275395)
2. Wang, X., and Tournier, C. (2006) Regulation of cellular functions by the ERK5 signalling pathway. Cell Signal. 18, 753-760 (Pubitemid 43208930)
3. Drew, B. A., Burow, M. E., and Beckman, B. S. (2012) MEK5/ERK5 pathway: the first fifteen years. Biochim. Biophys. Acta 1825, 37-48
4. Zhou, G., Bao, Z. Q., and Dixon, J. E. (1995) Components of a new human protein kinase signal transduction pathway. J. Biol. Chem. 270, 12665-12669
5. Kato, Y., Tapping, R. I., Huang, S., Watson, M. H., Ulevitch, R. J., and Lee, J. D. (1998) Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor. Nature 395, 713-716 (Pubitemid 28475970)
6. Raman, M., Chen, W., and Cobb, M. H. (2007) Differential regulation and properties of MAPKs. Oncogene 26, 3100-3112 (Pubitemid 46763006)
7. Cavanaugh, J. E., Ham, J., Hetman, M., Poser, S., Yan, C., and Xia, Z. (2001) Differential regulation of mitogen-activated protein kinases ERK1/2 and ERK5 by neurotrophins, neuronal activity, and cAMP in neurons. J. Neurosci. 21, 434-443 (Pubitemid 32107434)
8. Liu, L., Cundiff, P., Abel, G., Wang, Y., Faigle, R., Sakagami, H., Xu, M., and Xia, Z. (2006) Extracellular signal-regulated kinase (ERK) 5 is necessary and sufficient to specify cortical neuronal fate. Proc. Natl. Acad. Sci. U.S.A. 103, 9697-9702 (Pubitemid 43955887)
9. Regan, C. P., Li, W., Boucher, D. M., Spatz, S., Su, M. S., and Kuida, K. (2002) Erk5 null mice display multiple extraembryonic vascular and embryonic cardiovascular defects. Proc. Natl. Acad. Sci. U.S.A. 99, 9248-9253 (Pubitemid 34764599)
10. Sohn, S. J., Sarvis, B. K., Cado, D., and Winoto, A. (2002) ERK5 MAPK regulates embryonic angiogenesis and acts as a hypoxia-sensitive repressor of vascular endothelial growth factor expression. J. Biol. Chem. 277, 43344-43351 (Pubitemid 35285722)
11. Hayashi, M., Kim, S. W., Imanaka-Yoshida, K., Yoshida, T., Abel, E. D., Eliceiri, B., Yang, Y., Ulevitch, R. J., and Lee, J. D. (2004) Targeted deletion of BMK1/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure. J. Clin. Invest. 113, 1138-1148 (Pubitemid 38544099)
12. Pearson, G., English, J. M., White, M. A., and Cobb, M. H. (2001) ERK5 and ERK2 cooperate to regulate NF-B and cell transformation. J. Biol. Chem. 276, 7927-7931
13. Watson, F. L., Heerssen, H. M., Bhattacharyya, A., Klesse, L., Lin, M. Z., and Segal, R. A. (2001) Neurotrophins use the Erk5 pathway to mediate a retrograde survival response. Nat. Neurosci. 4, 981-988 (Pubitemid 32924137)
14. Buschbeck, M., and Ullrich, A. (2005) The unique C-terminal tail of the mitogen-activated protein kinase ERK5 regulates its activation and nuclear shuttling. J. Biol. Chem. 280, 2659-2667 (Pubitemid 40189370)
15. Kondoh, K., Terasawa, K., Morimoto, H., and Nishida, E. (2006) Regulation of nuclear translocation of extracellular signal-regulated kinase 5 by active nuclear import and export mechanisms. Mol. Cell. Biol. 26, 1679-1690
16. Caffrey, D. R., O'Neill, L. A., and Shields, D. C. (1999) The evolution of the MAP kinase pathways: coduplication of interacting proteins leads to new signaling cascades. J. Mol. Evol. 49, 567-582 (Pubitemid 32268713)
17. Li, M., Liu, J., and Zhang, C. (2011) Evolutionary history of the vertebrate mitogen activated protein kinases family. PloS One 6, e26999
18. Kato, Y., Kravchenko, V. V., Tapping, R. I., Han, J., Ulevitch, R. J., and Lee, J. D. (1997) BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J. 16, 7054-7066 (Pubitemid 27520805)
19. Liu, L., Cavanaugh, J. E., Wang, Y., Sakagami, H., Mao, Z., and Xia, Z. (2003) ERK5 activation of MEF2-mediated gene expression plays a critical role in BDNF-promoted survival of developing but not mature cortical neurons. Proc. Natl. Acad. Sci. U.S.A. 100, 8532-8537 (Pubitemid 36842579)
20. Potthoff, M. J., and Olson, E. N. (2007) MEF2: a central regulator of diverse developmental programs. Development 134, 4131-4140
21. Tanoue, T., Adachi, M., Moriguchi, T., and Nishida, E. (2000)Aconserved docking motif in MAP kinases common to substrates, activators, and regulators. Nat. Cell Biol. 2, 110-116
22. Bardwell, A. J., Frankson, E., and Bardwell, L. (2009) Selectivity of docking sites in MAPK kinases. J. Biol. Chem. 284, 13165-13173
23. Garai,Á ., Zeke, A., Gógl, G., Törio, I., Fördos, F., Blankenburg, H., Bárkai, T., Varga, J., Alexa, A., Emig, D., Albrecht, M., and Reményi, A. (2012) Specificity of linear motifs that bind to a common mitogen-activated protein kinase docking groove. Sci. Signal. 5, ra74
24. Chang, C. I., Xu, B. E., Akella, R., Cobb, M. H., and Goldsmith, E. J. (2002) Crystal structures of MAP kinase p38 complexed to the docking sites on its nuclear substrate MEF2A and activator MKK3b. Mol. Cell 9, 1241-1249 (Pubitemid 34722303)
25. Reményi, A., Good, M. C., Bhattacharyya, R. P., and Lim, W. A. (2005) The role of docking interactions in mediating signaling input, output, and discrimination in the yeast MAPK network. Mol. Cell 20, 951-962 (Pubitemid 41814883)
26. Gógl, G., Töro, I., and Reményi, A. (2012) Protein-peptide complex crystallization: a case study on the ERK2 mitogen-activated protein kinase. Acta Crystallogr. D Biol. Crystallogr., in press
27. Nakamura, K., and Johnson, G. L. (2003) PB1 domains of MEKK2 and MEKK3 interact with the MEK5 PB1 domain for activation of the ERK5 pathway. J. Biol. Chem. 278, 36989-36992 (Pubitemid 37175211)
28. Nakamura, K., and Johnson, G. L. (2007) Noncanonical function of MEKK2 and MEK5 PB1 domains for coordinated extracellular signalregulated kinase 5 and c-Jun N-terminal kinase signaling. Mol. Cell. Biol. 27, 4566-4577 (Pubitemid 46906577)
29. Nakamura, K., Uhlik, M. T., Johnson, N. L., Hahn, K. M., and Johnson, G. L. (2006) PB1 domain-dependent signaling complex is required for extracellular signal-regulated kinase 5 activation. Mol. Cell. Biol. 26, 2065-2079 (Pubitemid 43346911)
30. Hu, Q., Shen, W., Huang, H., Liu, J., Zhang, J., Huang, X., Wu, J., and Shi, Y. (2007) Insight into the binding properties of MEKK3 PB1 to MEK5 PB1 from its solution structure. Biochemistry 46, 13478-13489 (Pubitemid 350214358)
31. Kabsch, W. (2010) XDS. Acta Crystallogr. D Biol. Crystallogr. 66, 125-132
32. Winn, M. D., Ballard, C. C., Cowtan, K. D., Dodson, E. J., Emsley, P., Evans, P. R., Keegan, R. M., Krissinel, E. B., Leslie, A. G., McCoy, A., McNicholas, S. J., Murshudov, G. N., Pannu, N. S., Potterton, E. A., Powell, H. R., Read, R. J., Vagin, A., and Wilson, K. S. (2011) Overview of the CCP4 suite and current developments. Acta Crystallogr. D Biol. Crystallogr. 67, 235-242
33. McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., and Read, R. J. (2007) Phaser crystallographic software. J. Appl. Crystallogr. 40, 658-674 (Pubitemid 47080256)
34. Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L. W., Kapral, G. J., Grosse-Kunstleve, R. W., McCoy, A. J., Moriarty, N. W., Oeffner, R., Read, R. J., Richardson, D. C., Richardson, J. S., Terwilliger, T. C., and Zwart, P. H. (2010) PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213-221
35. Emsley, P., Lohkamp, B., Scott, W. G., and Cowtan, K. (2010) Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486 -501
36. Chen, V. B., Arendall, W. B., 3rd, Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., and Richardson, D. C. (2010) MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D Biol. Crystallogr. 66, 12-21
37. Barsyte-Lovejoy, D., Galanis, A., Clancy, A., and Sharrocks, A. D. (2004) ERK5 is targeted to myocyte enhancer factor 2A (MEF2A) through a MAPK docking motif. Biochem. J. 381, 693-699 (Pubitemid 39120478)
38. Ranganathan, A., Pearson, G. W., Chrestensen, C. A., Sturgill, T. W., and Cobb, M. H. (2006) The MAP kinase ERK5 binds to and phosphorylates p90 RSK. Arch Biochem. Biophys. 449, 8-16
39. Zhang, F., Strand, A., Robbins, D., Cobb, M. H., and Goldsmith, E. J. (1994) Atomic structure of the MAP kinase ERK2 at 2.3 A resolution. Nature 367, 704-711
40. Zhou, T., Sun, L., Humphreys, J., and Goldsmith, E. J. (2006) Docking interactions induce exposure of activation loop in the MAP kinase ERK2. Structure 14, 1011-1019 (Pubitemid 43831663)
41. Liu, S., Sun, J. P., Zhou, B., and Zhang, Z. Y. (2006) Structural basis of docking interactions between ERK2 and MAP kinase phosphatase 3. Proc. Natl. Acad. Sci. U.S.A. 103, 5326-5331
42. Ma, W., Shang, Y., Wei, Z., Wen, W., Wang, W., and Zhang, M. (2010) Phosphorylation of DCC by ERK2 is facilitated by direct docking of the receptor P1 domain to the kinase. Structure 18, 1502-1511
43. Jacobs, D., Glossip, D., Xing, H., Muslin, A. J., and Kornfeld, K. (1999) Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase. Genes Dev. 13, 163-175 (Pubitemid 29061947)
44. Bhattacharyya, R. P., Reményi, A., Good, M. C., Bashor, C. J., Falick, A. M., and Lim, W. A. (2006) The Ste5 scaffold allosterically modulates signaling output of the yeast mating pathway. Science 311, 822-826 (Pubitemid 43228840)
45. Murakami, Y., Tatebayashi, K., and Saito, H. (2008) Two adjacent docking sites in the yeast Hog1 mitogen-activated protein (MAP) kinase differentially interact with the Pbs2 MAP kinase kinase and the Ptp2 protein tyrosine phosphatase. Mol. Cell. Biol. 28, 2481-2494 (Pubitemid 351429991)
46. Aberg, E., Torgersen, K. M., Johansen, B., Keyse, S. M., Perander, M., and Seternes, O. M. (2009) Docking of PRAK/MK5 to the atypical MAPKs ERK3 and ERK4 defines a novel MAPK interaction motif. J. Biol. Chem. 284, 19392-19401
47. Piserchio, A., Warthaka, M., Devkota, A. K., Kaoud, T. S., Lee, S., Abramczyk, O., Ren, P., Dalby, K. N., and Ghose, R. (2011) SolutionNMRinsights into docking interactions involving inactive ERK2. Biochemistry 50, 3660-3672
48. Gupta, S., Campbell, D., Dérijard, B., and Davis, R. J. (1995) Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267, 389-393
49. Sharrocks, A. D., Yang, S. H., and Galanis, A. (2000) Docking domains and substrate-specificity determination forMAPkinases. Trends Biochem. Sci. 25, 448-453 (Pubitemid 30662413)
50. Zarrinpar, A., Park, S. H., and Lim, W. A. (2003) Optimization of specificity in a cellular protein interaction network by negative selection. Nature 426, 676-680 (Pubitemid 38009377)
51. Alexander, J., Lim, D., Joughin, B. A., Hegemann, B., Hutchins, J. R., Ehrenberger, T., Ivins, F., Sessa, F., Hudecz, O., Nigg, E. A., Fry, A. M., Musacchio, A., Stukenberg, P. T., Mechtler, K., Peters, J. M., Smerdon, S. J., and Yaffe, M. B. (2011) Spatial exclusivity combined with positive and negative selection of phosphorylation motifs is the basis for context-dependent mitotic signaling. Sci. Signal. 4, ra42
52. Moscat, J., Diaz-Meco, M. T., Albert, A., and Campuzano, S. (2006) Cell signaling and function organized by PB1 domain interactions. Mol. Cell 23, 631-640 (Pubitemid 44292560)
53. Zeke, A., Lukács, M., Lim, W. A., and Reményi, A. (2009) Scaffolds: interaction platforms for cellular signalling circuits. Trends Cell Biol. 19, 364-374
54. Bhattacharyya, R. P., Reményi, A., Yeh, B. J., and Lim, W. A. (2006) Domains, motifs, and scaffolds: the role of modular interactions in the evolution and wiring of cell signaling circuits. Ann Rev. Biochem. 75, 655- 680 (Pubitemid 44118047)
55. Guo, C., and Whitmarsh, A. J. (2008) The beta-arrestin-2 scaffold protein promotes c-Jun N-terminal kinase-3 activation by binding to its nonconserved N terminus. J. Biol. Chem. 283, 15903-15911
56. Won, A. P., Garbarino, J. E., and Lim, W. A. (2011) Recruitment interactions can override catalytic interactions in determining the functional identity of a protein kinase. Proc. Natl. Acad. Sci. U.S.A. 108, 9809 -9814
57. Milanesi, L., Petrillo, M., Sepe, L., Boccia, A., D'Agostino, N., Passamano, M., Di Nardo, S., Tasco, G., Casadio, R., and Paolella, G. (2005) Systematic analysis of human kinase genes: a large number of genes and alternative splicing events result in functional and structural diversity. BMC Bioinformatics 6, S20
58. Coulombe, P., and Meloche, S. (2007) Atypical mitogen-activated protein kinases: structure, regulation and functions. Biochim. Biophys. Acta 1773, 1376-1387 (Pubitemid 47125971)